The next board meeting for Madrigal Pharmaceuticals Inc is on 07 Aug 2025 for the purpose of Madrigal Pharmaceuticals Inc Second Quarter Earnings Results for 2025See details
Madrigal Pharmaceuticals Inc has a share price target of US$ 425, revenue growth forecast of 278.0%, and profit growth estimate of 37.4% for FY25, based on top 15 analyst calls.